Memphasys is rapidly hurtling towards commercialising of its “Felix” bio-separation IVF technology with clinical trials set to commence on the assessment of embryo fertilisations in patients at four Monash IVF Australian clinics. 104 couples are anticipated to commence trials in March 2022 with results due by December 2022 that are expected to support regulatory filings and international…
